Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.
Identifieur interne : 000583 ( PubMed/Corpus ); précédent : 000582; suivant : 000584Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.
Auteurs : Faizan Khan ; Alvi Rahman ; Marc Carrier ; Clive Kearon ; Sam Schulman ; Francis Couturaud ; Paolo Prandoni ; Sabine Eichinger ; Cecilia Becattini ; Giancarlo Agnelli ; Harry R. Büller ; Timothy A. Brighton ; Gualtiero Palareti ; Laurent Pinede ; Elham Sabri ; Brian Hutton ; George A. Wells ; Marc A. RodgerSource :
- BMJ open [ 2044-6055 ] ; 2017.
Abstract
For patients with a first unprovoked venous thromboembolism (VTE), the optimal duration of anticoagulation is a crucial clinical dilemma which has yet to be resolved. The decision to stop anticoagulant therapy (AT) after the initial 3-6 months or to continue AT indefinitely, is primarily governed by the long-term risk of recurrence when treatment is discontinued. This risk however, is not well established, hindering decision making.
DOI: 10.1136/bmjopen-2017-016950
PubMed: 28939565
Links to Exploration step
pubmed:28939565Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.</title><author><name sortKey="Khan, Faizan" sort="Khan, Faizan" uniqKey="Khan F" first="Faizan" last="Khan">Faizan Khan</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Rahman, Alvi" sort="Rahman, Alvi" uniqKey="Rahman A" first="Alvi" last="Rahman">Alvi Rahman</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Carrier, Marc" sort="Carrier, Marc" uniqKey="Carrier M" first="Marc" last="Carrier">Marc Carrier</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Kearon, Clive" sort="Kearon, Clive" uniqKey="Kearon C" first="Clive" last="Kearon">Clive Kearon</name><affiliation><nlm:affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Schulman, Sam" sort="Schulman, Sam" uniqKey="Schulman S" first="Sam" last="Schulman">Sam Schulman</name><affiliation><nlm:affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Couturaud, Francis" sort="Couturaud, Francis" uniqKey="Couturaud F" first="Francis" last="Couturaud">Francis Couturaud</name><affiliation><nlm:affiliation>Departmentof Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France.</nlm:affiliation></affiliation></author><author><name sortKey="Prandoni, Paolo" sort="Prandoni, Paolo" uniqKey="Prandoni P" first="Paolo" last="Prandoni">Paolo Prandoni</name><affiliation><nlm:affiliation>Department of Cardiovascular Sciences, Vascular Medicine Unit, University of Padua, Padua, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Eichinger, Sabine" sort="Eichinger, Sabine" uniqKey="Eichinger S" first="Sabine" last="Eichinger">Sabine Eichinger</name><affiliation><nlm:affiliation>Department of Medicine I, Medical University of Vienna, Vienna, Austria.</nlm:affiliation></affiliation></author><author><name sortKey="Becattini, Cecilia" sort="Becattini, Cecilia" uniqKey="Becattini C" first="Cecilia" last="Becattini">Cecilia Becattini</name><affiliation><nlm:affiliation>Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Agnelli, Giancarlo" sort="Agnelli, Giancarlo" uniqKey="Agnelli G" first="Giancarlo" last="Agnelli">Giancarlo Agnelli</name><affiliation><nlm:affiliation>Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Buller, Harry R" sort="Buller, Harry R" uniqKey="Buller H" first="Harry R" last="Büller">Harry R. Büller</name><affiliation><nlm:affiliation>Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Brighton, Timothy A" sort="Brighton, Timothy A" uniqKey="Brighton T" first="Timothy A" last="Brighton">Timothy A. Brighton</name><affiliation><nlm:affiliation>Department of Haematology, Prince of Wales Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Palareti, Gualtiero" sort="Palareti, Gualtiero" uniqKey="Palareti G" first="Gualtiero" last="Palareti">Gualtiero Palareti</name><affiliation><nlm:affiliation>University of Bologna, Bologna, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Pinede, Laurent" sort="Pinede, Laurent" uniqKey="Pinede L" first="Laurent" last="Pinede">Laurent Pinede</name><affiliation><nlm:affiliation>Department of Internal Medicine, Infirmerie Protestante, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Sabri, Elham" sort="Sabri, Elham" uniqKey="Sabri E" first="Elham" last="Sabri">Elham Sabri</name><affiliation><nlm:affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Hutton, Brian" sort="Hutton, Brian" uniqKey="Hutton B" first="Brian" last="Hutton">Brian Hutton</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Wells, George A" sort="Wells, George A" uniqKey="Wells G" first="George A" last="Wells">George A. Wells</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Rodger, Marc A" sort="Rodger, Marc A" uniqKey="Rodger M" first="Marc A" last="Rodger">Marc A. Rodger</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28939565</idno><idno type="pmid">28939565</idno><idno type="doi">10.1136/bmjopen-2017-016950</idno><idno type="wicri:Area/PubMed/Corpus">000583</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000583</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.</title><author><name sortKey="Khan, Faizan" sort="Khan, Faizan" uniqKey="Khan F" first="Faizan" last="Khan">Faizan Khan</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Rahman, Alvi" sort="Rahman, Alvi" uniqKey="Rahman A" first="Alvi" last="Rahman">Alvi Rahman</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Carrier, Marc" sort="Carrier, Marc" uniqKey="Carrier M" first="Marc" last="Carrier">Marc Carrier</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Kearon, Clive" sort="Kearon, Clive" uniqKey="Kearon C" first="Clive" last="Kearon">Clive Kearon</name><affiliation><nlm:affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Schulman, Sam" sort="Schulman, Sam" uniqKey="Schulman S" first="Sam" last="Schulman">Sam Schulman</name><affiliation><nlm:affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Couturaud, Francis" sort="Couturaud, Francis" uniqKey="Couturaud F" first="Francis" last="Couturaud">Francis Couturaud</name><affiliation><nlm:affiliation>Departmentof Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France.</nlm:affiliation></affiliation></author><author><name sortKey="Prandoni, Paolo" sort="Prandoni, Paolo" uniqKey="Prandoni P" first="Paolo" last="Prandoni">Paolo Prandoni</name><affiliation><nlm:affiliation>Department of Cardiovascular Sciences, Vascular Medicine Unit, University of Padua, Padua, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Eichinger, Sabine" sort="Eichinger, Sabine" uniqKey="Eichinger S" first="Sabine" last="Eichinger">Sabine Eichinger</name><affiliation><nlm:affiliation>Department of Medicine I, Medical University of Vienna, Vienna, Austria.</nlm:affiliation></affiliation></author><author><name sortKey="Becattini, Cecilia" sort="Becattini, Cecilia" uniqKey="Becattini C" first="Cecilia" last="Becattini">Cecilia Becattini</name><affiliation><nlm:affiliation>Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Agnelli, Giancarlo" sort="Agnelli, Giancarlo" uniqKey="Agnelli G" first="Giancarlo" last="Agnelli">Giancarlo Agnelli</name><affiliation><nlm:affiliation>Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Buller, Harry R" sort="Buller, Harry R" uniqKey="Buller H" first="Harry R" last="Büller">Harry R. Büller</name><affiliation><nlm:affiliation>Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Brighton, Timothy A" sort="Brighton, Timothy A" uniqKey="Brighton T" first="Timothy A" last="Brighton">Timothy A. Brighton</name><affiliation><nlm:affiliation>Department of Haematology, Prince of Wales Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Palareti, Gualtiero" sort="Palareti, Gualtiero" uniqKey="Palareti G" first="Gualtiero" last="Palareti">Gualtiero Palareti</name><affiliation><nlm:affiliation>University of Bologna, Bologna, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Pinede, Laurent" sort="Pinede, Laurent" uniqKey="Pinede L" first="Laurent" last="Pinede">Laurent Pinede</name><affiliation><nlm:affiliation>Department of Internal Medicine, Infirmerie Protestante, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Sabri, Elham" sort="Sabri, Elham" uniqKey="Sabri E" first="Elham" last="Sabri">Elham Sabri</name><affiliation><nlm:affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Hutton, Brian" sort="Hutton, Brian" uniqKey="Hutton B" first="Brian" last="Hutton">Brian Hutton</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Wells, George A" sort="Wells, George A" uniqKey="Wells G" first="George A" last="Wells">George A. Wells</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Rodger, Marc A" sort="Rodger, Marc A" uniqKey="Rodger M" first="Marc A" last="Rodger">Marc A. Rodger</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author></analytic><series><title level="j">BMJ open</title><idno type="eISSN">2044-6055</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">For patients with a first unprovoked venous thromboembolism (VTE), the optimal duration of anticoagulation is a crucial clinical dilemma which has yet to be resolved. The decision to stop anticoagulant therapy (AT) after the initial 3-6 months or to continue AT indefinitely, is primarily governed by the long-term risk of recurrence when treatment is discontinued. This risk however, is not well established, hindering decision making.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28939565</PMID><DateCreated><Year>2017</Year><Month>09</Month><Day>23</Day></DateCreated><DateRevised><Year>2017</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>16950</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2017-016950</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">For patients with a first unprovoked venous thromboembolism (VTE), the optimal duration of anticoagulation is a crucial clinical dilemma which has yet to be resolved. The decision to stop anticoagulant therapy (AT) after the initial 3-6 months or to continue AT indefinitely, is primarily governed by the long-term risk of recurrence when treatment is discontinued. This risk however, is not well established, hindering decision making.</AbstractText><AbstractText Label="METHODS AND ANALYSIS" NlmCategory="UNASSIGNED">We will conduct a systematic review and a meta-analysis of studies involving patients diagnosed with a first, symptomatic unprovoked VTE or VTE provoked by minor transient risk factors, who have completed at least 3 months of initial AT; and who were followed-up for standardised time intervals of 1, 2, 5, 10 and 20 years (±3 months) after stopping AT. We will search (from inception to January 2017) MEDLINE, Embase and the Cochrane library for randomised controlled trials and prospective observational studies. Two reviewers will conduct all screening and data collection independently. The primary outcome of the rate of recurrent VTE at the standardised time intervals will be calculated for each study from the total number of recurrent events and the corresponding number of patient-years of follow-up. We will use a random-effects model to pool study results and report a weighted estimate of the absolute rate of recurrent VTE (events per 100 patient-years) over standardised time intervals of 1, 2, 5, 10 and 20 years after discontinuing anticoagulants.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="UNASSIGNED">Ethical approval is not applicable for this study. Findings from this study will be disseminated through peer-reviewed journal publication as well as relevant national and international conference presentations.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER" NlmCategory="UNASSIGNED">CRD42017056309.</AbstractText><CopyrightInformation>© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Faizan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Alvi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrier</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ottawa Blood Disease Centre, The Ottawa Hospital, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kearon</LastName><ForeName>Clive</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulman</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couturaud</LastName><ForeName>Francis</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Departmentof Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prandoni</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, Vascular Medicine Unit, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eichinger</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine I, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becattini</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnelli</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Büller</LastName><ForeName>Harry R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brighton</LastName><ForeName>Timothy A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Haematology, Prince of Wales Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palareti</LastName><ForeName>Gualtiero</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinede</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Infirmerie Protestante, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabri</LastName><ForeName>Elham</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hutton</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>George A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodger</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ottawa Blood Disease Centre, The Ottawa Hospital, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>MARVELOUS Collaborators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Thromb Haemost. 2012 Jun;10(6):1019-25</RefSource><PMID Version="1">22489957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2014 Sep 23;130(13):1062-71</RefSource><PMID Version="1">25156992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2017 Dec 17;388(10063):3060-3073</RefSource><PMID Version="1">27375038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2013 Aug 30;347:f5133</RefSource><PMID Version="1">23996149</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cardiol. 2015 Aug;12(8):464-74</RefSource><PMID Version="1">26076949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011 Feb 24;342:d813</RefSource><PMID Version="1">21349898</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2017 Mar 17;356:j1065</RefSource><PMID Version="1">28314711</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Syst Rev. 2015 Jan 01;4:1</RefSource><PMID Version="1">25554246</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thromb Haemost. 2016 Jul;14(7):1480-3</RefSource><PMID Version="1">27428935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arzneimittelforschung. 1992 May;42(5):587-91</RefSource><PMID Version="1">1388359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Med Res Methodol. 2007 Feb 15;7:10</RefSource><PMID Version="1">17302989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2008 Oct 7;149(7):481-90, W94</RefSource><PMID Version="1">18838728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2015 Jul 7;314(1):31-40</RefSource><PMID Version="1">26151264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood Rev. 2010 Jul-Sep;24(4-5):171-8</RefSource><PMID Version="1">20633967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chest. 2016 Feb;149(2):315-52</RefSource><PMID Version="1">26867832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CMAJ. 2008 Aug 26;179(5):417-26</RefSource><PMID Version="1">18725614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2015 Jan 02;349:g7647</RefSource><PMID Version="1">25555855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thromb Haemost. 2005 Apr;3(4):692-4</RefSource><PMID Version="1">15842354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2010 May 4;152(9):578-89</RefSource><PMID Version="1">20439576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Thromb Res. 2016 Jul;143:152-8</RefSource><PMID Version="1">27086275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k</RefSource><PMID Version="1">25173341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011 May 24;342:d3036</RefSource><PMID Version="1">21610040</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Epidemiol. 2011 Nov;64(11):1187-97</RefSource><PMID Version="1">21477993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Epidemiol. 2011 Apr;64(4):401-6</RefSource><PMID Version="1">21208779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thromb Haemost. 2016 Dec;14 (12 ):2402-2409</RefSource><PMID Version="1">27696701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011 Oct 18;343:d5928</RefSource><PMID Version="1">22008217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2014 Mar 20;123(12):1794-801</RefSource><PMID Version="1">24497538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2010 Apr 13;121(14):1630-6</RefSource><PMID Version="1">20351233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thromb Haemost. 2010 Oct;8(10):2313-5</RefSource><PMID Version="1">20738761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2009 Jul 21;6(7):e1000097</RefSource><PMID Version="1">19621072</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anticaogulants</Keyword><Keyword MajorTopicYN="N">recurrence</Keyword><Keyword MajorTopicYN="N">venous thrombosis</Keyword></KeywordList><CoiStatement>Competing interests: MC reports receiving research support form Leo Pharma and BMS, and honoraria from Pfizer, Bayer, BMS, and Sanofi, outside the submitted work. SS reports receiving honoraria from Boehringer Ingelheim, Bayer HealthCare, Daiichi Sankyo and Sanofi, and research support from Boehringer Ingelheim, Baxter and Octapharma, outside the submitted work. FC reports having received research grant support from Pfizer, honoraria for board memberships or symposia from Bayer and AstraZeneca, and travel support from Bayer, Daiichi Sankyo, Leo Pharma, Intermune, and Actelion, outside the submitted work. PP reports receiving consultancy and lectures fees from Bayer Pharma, Sanofi, Daiichi-Sankyo and Pfizer, outside the submitted work. CB reports receiving lectures fees from Bayer HealthCare, Bristol Meyer Squibb and Boehringer Ingelheim, outside the submitted work. GA reports personal fees from Bristol-Myers-Squibb, Pfizer, Bayer Healthcare, Boehringer Ingelheim, and Daiichi Sankyo, outside the submitted work. HRB reports receiving research support and consultancy fees from Sanofi-aventis, Bayer HealthCare, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Pfizer, Roche, Isis, Thrombogenics, and Boehringer Ingelheim, outside the submitted work. TAB reports receiving personal fees from Bayer, Bayer Australia, Novo Nordisk, and Glaxo Smith Klein, outside the submitted work. GP reports Advisory Board for Alfa-Wassermann, Daiichi-Sankyo, Pfizer and Roche, and speaker fees from Werfen, outside the submitted work. BH reports receiving honoraria from Cornerstone Research Group for provision of methodologic advice related to systematic reviews and meta-analysis. MAR reports receiving research support from Biomerieux, outside of the submitted work. All other authors (FK, AR, CK, SE, LP, ES and GAW) declare that they have no relevant competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28939565</ArticleId><ArticleId IdType="pii">bmjopen-2017-016950</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2017-016950</ArticleId><ArticleId IdType="pmc">PMC5623531</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000583 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000583 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28939565
|texte= Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28939565" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |